Therapy News and Research

RSS

Novel decoding technology could predict mood variations from brain signals

By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain--a process that has not been demonstrated to date.

10 Sep 2018

BAP1 protein serves as tumor suppressor gene in kidney, eye, bile duct and mesothelioma cancers

Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor gene in kidney, eye, bile duct, mesothelioma and other cancers by regulating a form of cell death called ferroptosis, opening up a potential new area of therapy research.

10 Sep 2018

Study provides evidence to prevent memory decline in older blacks with mild cognitive impairment

With nearly twice the rate of dementia as whites, blacks are at a higher risk for developing diseases like Alzheimer's, but there has been little research on how to reduce this racial health disparity.

10 Sep 2018

Individualized therapies targeting specific features show promise in transforming cancer treatment

Individualized therapies that target the specific genetic features of tumors have the potential to transform cancer diagnosis, treatment and care.

10 Sep 2018

New paper reports conserved collateral susceptibility to antibiotics in E. coli

LSTM's Dr Adam Roberts is a co-author on a new paper published in Nature Communications which reports conserved collateral susceptibility to antibiotics in the human pathogen Escherichia coli.

10 Sep 2018

New legislation to provide licensure clarity for sports medicine professionals passes the U.S. Senate

The Sports Medicine Licensure Clarity Act (S. 808) has successfully passed the U.S. Senate, taking another critical step forward.

10 Sep 2018

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.

7 Sep 2018

Family genetic background essential for understanding autism progression

Whether an individual develops a neurodevelopmental disorder like autism or ADHD and the severity of that disorder depends on genetic changes beyond a single supposedly disease-causing mutation.

7 Sep 2018

Major pitfall identified in popular prostate cancer PET imaging method

Prostate-specific membrane antigen positron emission tomography imaging has become a popular method for determining the stage of a patient's prostate cancer.

7 Sep 2018

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.

7 Sep 2018

Hsp90 protein appears to stimulate exosome release

Researchers from the Verstreken lab have identified a completely novel function for Hsp90, one of the most common and most studied proteins in our body.

7 Sep 2018

Study analyzes what happens in the brain when humans forget something on purpose

Researchers from Ruhr-Universität Bochum and the University Hospital of Gieβen and Marburg, in collaboration with colleagues from Bonn, the Netherlands, and the UK, have analyzed what happens in the brain when humans want to voluntarily forget something.

7 Sep 2018

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

Among a small cohort of patients with HIV-associated Kaposi's sarcoma treated with immune checkpoint inhibitors, more than 65 percent had partial or complete remission.

7 Sep 2018

Study reinvestigates benefit of biomarker tests in certain breast cancer patients

The German Institute for Quality and Efficiency in Health Care reinvestigated the benefit of biomarker tests to support the decision for or against adjuvant systemic chemotherapy in certain breast cancer patients, that is, women with primary hormone receptor-positive, HER2/neu-negative breast cancer and 0 to 3 affected lymph nodes.

7 Sep 2018

Researchers test experimental cancer vaccine on mice with aggressive melanoma

An experimental cancer vaccine that boosts the immune system's ability to fight cancers could work in tandem with other cancer therapies to fight aggressive tumors, scientists reported recently in the Proceedings of the National Academy of Sciences.

7 Sep 2018

Imaging with CMR can improve detection of cardiac injury in lupus patients

The number of diagnoses of systemic lupus erythematodes has tripled over the past 45 years - due in part to improved diagnostic methods.

7 Sep 2018

Transcranial direct current stimulation may help aphasia patients recover use of language

Neuroscientists at the University of South Carolina and the Medical University of South Carolina have collaborated on a study in the field of aphasia that has successfully paved the way for a large clinical trial.

7 Sep 2018

UNC and Cell Microsystems receive NIH Phase I SBIR contract to develop HIV diagnostic assay

The University of North Carolina at Chapel Hill HIV Cure Center and Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced they have received an approximately $283,000, 12-month Phase I Small Business Innovation and Research contract from the National Institutes of Health to develop an automated platform to quantify the latent HIV reservoir.

7 Sep 2018

Mayo Clinic physicians win SU2C Catalyst Award to fund melanoma research

Mayo Clinic physicians Matthew Block, M.D., Ph.D. and Tina Hieken, M.D., have received a Stand up to Cancer Catalyst Award to fund melanoma research and a neoadjuvant clinical trial.

7 Sep 2018

Research team identifies new therapeutic target for castration-resistant prostate cancer

A collaborative research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor expression in prostate cancer cells, identifying a new therapeutic target for one of the deadliest forms of cancer among men.

7 Sep 2018

Therapy News and Research

Novel decoding technology could predict mood variations from brain signals

BAP1 protein serves as tumor suppressor gene in kidney, eye, bile duct and mesothelioma cancers

Study provides evidence to prevent memory decline in older blacks with mild cognitive impairment

Individualized therapies targeting specific features show promise in transforming cancer treatment

New paper reports conserved collateral susceptibility to antibiotics in E. coli

New legislation to provide licensure clarity for sports medicine professionals passes the U.S. Senate

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

Family genetic background essential for understanding autism progression

Major pitfall identified in popular prostate cancer PET imaging method

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Hsp90 protein appears to stimulate exosome release

Study analyzes what happens in the brain when humans forget something on purpose

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

Study reinvestigates benefit of biomarker tests in certain breast cancer patients

Researchers test experimental cancer vaccine on mice with aggressive melanoma

Imaging with CMR can improve detection of cardiac injury in lupus patients

Transcranial direct current stimulation may help aphasia patients recover use of language

UNC and Cell Microsystems receive NIH Phase I SBIR contract to develop HIV diagnostic assay

Mayo Clinic physicians win SU2C Catalyst Award to fund melanoma research

Research team identifies new therapeutic target for castration-resistant prostate cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News